InvestorsHub Logo

BooDog

11/24/20 6:20 PM

#334733 RE: krobar #334728

...announces today that an overseas Clinical Trial Application (CTA) has been submitted to the governing health agency, with a U.S. Investigational New Drug (IND) application also to be submitted this week to the FDA. Both these submissions are part of final preparations for the Company’s multinational Phase 2 clinical trial of Brilacidin for COVID-19, which is on track to commence in 2020 upon gaining required approvals.

This was just last week. Still time to kick off recruiting announcements by the end of the year.

http://www.ipharminc.com/press-release/2020/11/15/innovation-pharmaceuticals-announces-overseas-regulatory-filing-submitted-for-covid-19-clinical-study

Momentum starts coming in I'm in a cash position set to double down here.

Lemoncat

11/24/20 7:32 PM

#334742 RE: krobar #334728

We should have our trial started by Dec 31 and results in the 1H2021. Operation IPIX Warp Speed is commencing!

Take this time to stock up on shares.

Go IPIX!